A clinical study to Evaluate antipyretic effect of Febrikid plus tablet in Children

A Randomized Controlled Clinical study to evaluate the antipyretic effect of Febrikid Plus Tablets in children with febrile state. - nil

Status

Active, not recruiting

Phases

Phase 2Phase 3

Study type

Interventional

Source

CTRI

Registry ID

CTRI/2023/07/055248

Enrollment

Registered

2023-07-14

Start date

Unknown

Completion date

Unknown

Last updated

2023-07-25

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: B999- Unspecified infectious disease

Interventions

None listed

Eligibility

Inclusion criteria

Inclusion criteria: 1.Temperature between 99- 103 oF. 2.Fever of acute onset without any complications i.e. dehydration, convulsion, etc. 3.Acute onset fever of 1 to 3 days. 4.Patient of either sex suffering from fever of age 3-12 years. 5.Children with parents who agree to participate and sign the informed consent

Exclusion criteria

Exclusion criteria: 1.Fever more than 3 days. 2.Chronic fever ( > 5 days) associated with poor hemodynamic and clinical outcomes. 3.Any febrile condition of children requiring an immediate intervention depending of history and general condition at the point of examination as found by the investigators non inducible was be excluded from study

Design outcomes

Primary

Measure	Time frame
Reduced in Fever & Body Temerature Reduced in Body ache & headache Improvement in appetiteTimepoint: At baseline On Day 2 Day 3 Day 5	—

Secondary

Measure	Time frame
Improvement in Leg cramps Improvement in Weakness Reduced IrritabilityTimepoint: 4 days 5 days 6 days	—

Countries

India

Contacts

Public ContactDr Dipeeka Surwase

Parul Institue of Ayurveda

neonatecare22@gmail.com9726587013

Outcome results